secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0001493152-23-017799
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics adopts change-in-control severance plan; CEO 3x, CFO 2x multipliers
--------------------------------------------------------------------------------

- Board approved Change in Control Severance Plan for select management; CEO Dwight Egan gets 3x multiplier, CFO Brian Brown gets 2x.
- Severance benefit = multiplier times (base salary + greater of target bonus or avg of three highest actual bonuses).
- Benefits triggered by termination without cause or for good reason within 2 years after a change in control.
- Payment is lump sum after signing separation agreement; subject to Section 409A limitations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315223017799/0001493152-23-017799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315223017799/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer